Chemistry - A European Journal
10.1002/chem.201800168
COMMUNICATION
indicated by the ITC data. Thus, whereas the IDA group only Acknowledgements
directs the PMOx via weak interactions to the surface of HRP,
subsequent stronger binding of the polymer is induced by
dehydration of the interacting interfaces.
According to its non-competitive character, the IDA terminated
PMOx does not attach directly to the heme group of the active
3
center. Thus, CH -PMOx-IDA attached to the enzyme surface
The authors of this paper would like to thank Thorsten Moll for
[17]
performing size exclusion chromatography and Dr. W. Hiller for
1
performing
H
NMR measurements. All polymers were
synthesized using CEM Discover microwaves, which were kindly
provided by CEM for undergraduate student education. DFG.
can either influence the protein conformation by changes of
surface polarity and/or by blocking the active site. CD spectra do
not show strong changes in protein conformation, which
supports the latter possibility. The fact that the polymer is
capable of fully inhibiting the enzyme is also an indication of
blocking the active site. Dynamic light scattering (DLS) data,
which show no formation of larger aggregates between HRP and
.
Keywords: Enzyme inhibitor, Poly(2-oxazoline), horse radish
peroxidase, functional polymer end groups
[
1] a) R. Copeland, Evaluation of Enzyme Inhibitors in Drug Discovery: A
3
CH -PMOx-IDA in water using the same concentration as
Guide for Medicinal Chemists and Pharmacologists, Second Edition
|, John Wiley & Sons, 2013, p; b) M. R. Arkin and J. A. Wells, Nat Rev Drug
Discov 2004, 3, 301-317.
applied for the ITC measurements, show that the IDA-terminated
polymers do not form a shell of many attaching polymers around
the protein (Figure S10, Supplement). This suggests specific
binding between protein and polymer at one binding site, which
could be near the active site. Nevertheless, these are only
indicators that are not excluding that a small conformational
change of the protein by changed polarity at the surface, found
[
2] T. Kimura, K. Sato, K. Sugimoto, R. Tao, T. Murakami, Y. Kurosaki and T.
Nakayama, Biological & Pharmaceutical Bulletin 1996, 19, 897-900.
3] R. Duncan, J. K. Coatsworth and S. Burtles, Human & Experimental
Toxicology 1998, 17, 93-104.
4] S. M. Ryan, G. Mantovani, X. Wang, D. M. Haddleton and D. J. Brayden,
Expert Opinion on Drug Delivery 2008, 5, 371-383.
5] P. Vivek Kumar, K. Saravanakumar, P. Nagaveni, A. Mohan Kumar and B.
[
[
[
Ramesh, International Journal of Research in Pharmaceutical Sciences 2016,
205-215%V 205.
[
21]
for liposome attaching PMOx, is responsible for the inhibition.
[
6] A. Bernkop-Schnurch, H. Zarti and G. F. Walker, Journal of Pharmaceutical
Sciences 2001, 90, 1907-1914.
7] A. Bernkop-Schnurch and C. E. Kast, Advanced Drug Delivery Reviews
2001, 52, 127-137.
8] M. K. Marschütz and A. Bernkop-Schnürch, Biomaterials 2000, 21, 1499-
507.
In order to broaden the validity of the shown concept, guaiacol
as second substrate was used and the inhibition of HRP in the
presence of IDA-PMOx33-IDA (1.25-7.5 mM) was investigated.
Similar results were obtained when using guaiacol as substrate
instead of ABTS (Figure S11, supplements). When fitting the
obtained kinetic data with the classic Michaelis-Menten-Model,
[
[
1
[9] C. P. Fik, S. Konieczny, D. H. Pashley, C. J. Waschinski, R. S. Ladisch, U.
Salz, T. Bock and J. C. Tiller, Macromolecular Bioscience 2014, 14, 1569-
1
579.
[
10] M. Schmidt, L. K. Bast, F. Lanfer, L. Richter, E. Hennes, R. Seymen, C.
kcat/K
M
(for guaiacol as substrate) changes from 6200 ± 900 to
Krumm and J. C. Tiller, Bioconjugate Chemistry 2017.
-1
-1
[11] M. Schmidt, L. K. Bast, F. Lanfer, L. Richter, E. Hennes, R. Seymen, C.
Krumm and J. C. Tiller, Bioconjugate Chemistry 2017, 28, 2440-2451.
[12] E. Cohen, Archives of Insect Biochemistry and Physiology 1993, 22, 245-
2100 ± 500 L·s ·mol ) when adding the polymeric inhibitor,
indicating non-competitive inhibition.
261.
In order to test if alkylated IDA group needs to be attached to the
polymer terminal for efficient HRP inhibition, the model
compound 2,2'-(propylazanediyl)diacetic acid (Pro-IDA) was
[
13] H. L. Lueßen, C. M. Lehr, C. O. Rentel, A. B. J. Noach, A. G. de Boer, J.
C. Verhoef and H. E. Junginger, Journal of Controlled Release 1994, 29, 329-
338.
[
14] G. Borchard, H. L. Lueβen, A. G. de Boer, J. C. Verhoef, C.-M. Lehr and
synthesized. This compound was mixed with the CH3-PMOx31
-
H. E. Junginger, Journal of Controlled Release 1996, 39, 131-138.
[15] P. Goddard, L. E. Hutchinson, J. Brown and L. J. Brookman, Journal of
Controlled Release 1989, 10, 5-16.
OH in 1:1 molar ratio and tested for HRP inhibition in the guiacol
test at the 7.5 mM. No significant inhibition could be observed
indicating that only the IDA-terminated PMOx is the inhibitor.
In closing, we have shown in this study that the combination of a
non-active polymer and a protein-binding group that is no
inhibitor can result in an effective enzyme inhibitor. The ITC data
suggest that weak interactions between the end group of the
polymer and the protein are sufficient to obtain a strong bond,
because the polymer/protein binding is driven by entropy. Thus,
this new inhibitor concept offers the chance to find new enzyme
inhibitors as pharmaceuticals, pesticides, or antibiotics by
combining so far not considered non-inhibiting but enzyme
binding functions with hydrophilic polymers. Such conjugates
might have different toxicology and immunology profiles
compared to currently used systems.
[
[
16] D. Tarn, M. Xue and J. I. Zink, Inorganic Chemistry 2013, 52, 2044-2049.
17] Q. Wei, T. Becherer, S. Angioletti-Uberti, J. Dzubiella, C. Wischke, A. T.
Neffe, A. Lendlein, M. Ballauff and R. Haag, Angewandte Chemie International
Edition 2014, 53, 8004-8031.
[
18] M. M. Lopez and D. Kosk-Kosicka, Biochemistry 1997, 36, 8864-8872.
[19] A. Miklavc and D. Kocjan, Journal of Chemical Information and Computer
Sciences 2004, 44, 422-426.
[
20] F. Zhao, X. Cheng, G. Liu and G. Zhang, The Journal of Physical
Chemistry B 2010, 114, 1271-1276.
[21] C. J. Waschinski, S. Barnert, A. Theobald, R. Schubert, F. Kleinschmidt, A.
Hoffmann, K. Saalwächter and J. C. Tiller, Biomacromolecules 2008, 9, 1764-
1771.
This article is protected by copyright. All rights reserved.